Table 3.
Patient information
| N = 84 | N | |
|---|---|---|
|
Median age |
|
|
|
(interquartile range) |
65 (53 – 70) |
|
|
Gender |
Male |
45 |
| |
Female |
39 |
|
Performance status |
0 – 1 |
61 |
| |
≥ 2 |
23 |
|
Histology |
Adenocarcinoma |
50 |
| |
Squamous Carcinoma |
15 |
| |
PDC/UDC |
15 |
| |
Malignant Neoplasm |
4 |
|
Differentiation (grade) |
1 |
7 |
| |
2 |
33 |
| |
3 |
44 |
|
Clinicopathologic subgroup |
Visceral |
29 |
| |
Axillary nodal |
9 |
| |
Peritoneal carcinomatosis |
18 (15/3) |
| |
(Serous/Mucinous) |
|
| |
Midline nodal |
10 |
| |
Squamous cervical nodal |
18 |
|
Chemotherapy |
Chemo (Yes / No) |
63/ 21 |
| |
Platinum-based |
27 |
| |
Platinum + Taxane |
23 |
| |
Taxane-based |
3 |
| |
Other |
10 |
|
Median PFS (95% CI) |
|
7 months (4.8 – 9.2) |
| Median OS (95% CI) | 12 months (8.7 – 15.3) |